Ajanta Pharma Ltd. logo

Ajanta Pharma Ltd. (AJANTPHARM)

Market Closed
5 Aug, 10:00
XNSE XNSE
3,437. 50
-87.6
-2.485%
374.97B Market Cap
- P/E Ratio
112% Div Yield
126,574 Volume
- Eps
3,525.1
Previous Close
Add Transaction
Day Range
3,403.1 3,527.9
Year Range
2,329.9 3,598.8
Want to track AJANTPHARM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

AJANTPHARM closed today lower at ₹3,437.5, a decrease of -2.485% from yesterday's close, completing a monthly increase of 0.4324% or ₹14.8. Over the past 12 months, AJANTPHARM stock gained 23.314%.
AJANTPHARM pays dividends to its shareholders, with the most recent payment made on Dec 03, 2025. The next announced payment will be in In 1 weeks on Aug 18, 2026 for a total of ₹32.
The last earnings report, released on Apr 30, 2026, missed the consensus estimates by -20.85%. On average, the company has fell short of earnings expectations by -6.2033%, based on the last three reports.
Ajanta Pharma Ltd. has completed 4 stock splits, with the recent split occurring on Jun 22, 2022.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).

AJANTPHARM Chart

People also search for

Sun Pharmaceutical Industries Ltd.
1,940
-1.222%
Tata Motors Ltd.
349.8
+0.3586%
Maruti Suzuki India Limited
14,165
-0.0212%
M&M
Mahindra & Mahindra Ltd.
3,455.4
+0.6525%
Bajaj Auto Limited
11,800
+1.7241%

Ajanta Pharma Ltd. (AJANTPHARM) FAQ

What is the stock price today?

The current price is ₹3,437.50.

On which exchange is it traded?

Ajanta Pharma Ltd. is listed on XNSE.

What is its stock symbol?

The ticker symbol is AJANTPHARM.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 112%.

What is its market cap?

As of today, the market cap is 374.97B.

Has Ajanta Pharma Ltd. ever had a stock split?

Ajanta Pharma Ltd. had 4 splits and the recent split was on Jun 22, 2022.

Ajanta Pharma Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Yogesh Mannalal Agrawal M.B.A CEO
XNSE Exchange
Y0R6E1145 CUSIP
India Country
8,073 Employees
5 Aug 2026 Last Dividend
20 Mar 2015 Last Split
- IPO Date

Overview

Ajanta Pharma Limited is a revered entity in the specialty pharmaceutical sector, known for its integrated approach to developing, manufacturing, and marketing pharmaceutical finished dosages. With a history that dates back to 1973, the company has established a significant footprint. Headquartered in Mumbai, India, Ajanta Pharma extends its services across diverse global markets, including Africa, other parts of Asia, the United States, and beyond. Catering to a variety of therapeutic segments like cardiology, antidiabetic, ophthalmology, dermatology, pain management, and respiratory areas, the company stands out for its commitment to addressing a broad spectrum of healthcare needs.

Products and Services

List of key offerings by Ajanta Pharma Limited:

  • Cardiology products:

    Ajanta Pharma provides a comprehensive range of formulations designed to treat cardiovascular diseases, supporting patients with advanced therapeutics for heart health.

  • Antidiabetic products:

    The company offers a variety of medicines aimed at managing diabetes, demonstrating its focus on chronic conditions that require ongoing care and sophisticated treatment regimens.

  • Ophthalmology products:

    Ajanta Pharma’s ophthalmology division develops products for eye care, addressing conditions that range from routine problems to complex diseases requiring specialized treatment.

  • Dermatology products:

    With a focus on skin health, the company’s dermatology products include treatments for a wide range of skin conditions, ensuring solutions for both common and rare dermatological challenges.

  • Pain management products:

    Catering to the pain management segment, Ajanta Pharma provides medications designed to alleviate various types of pain, offering relief and improving the quality of life for patients dealing with chronic or acute pain.

  • Respiratory products:

    The company’s respiratory range includes treatments for disorders of the respiratory system, supporting individuals suffering from conditions that impact breathing and lung function.

  • Tablets, Capsules, Injectables:

    Ajanta Pharma’s portfolio extends to a wide array of dosage forms, including tablets, capsules, and injectables, accommodating different therapeutic needs and preferences.

  • Inhalers, Ointments, Creams, and Liquids:

    Further diversifying its product lineup, the company offers inhalers for respiratory issues, along with topical ointments, creams for dermatological use, and liquid formulations, ensuring comprehensive healthcare solutions.

Contact Information

Address: Ajanta House
Phone: 91 22 6606 1000